Metabolic aspects of cardiac arrhythmias by Gizurarson, Sigfús
Metabolic aspects of cardiac arrhythmias
Akademisk avhandling
som för avläggande av medicine doktorsexamen vid Sahlgrenska akademin vid Göteborgs 
Universitet kommer att offentligen försvaras I hörsal Arvid Carlsson, Medicinaregatan 3, 
Göteborg
Fredagen den 25 maj 2012 kl. 13.00
av
Sigfús Gizurarson
Fakultetsopponent:
Professor David Erlinge
Lunds Universitet
The thesis is based on the following papers,
I. Sigfus Gizurarson, Malin Lorentzon, Truls Råmunddal, Finn Waagstein, Lennart Bergfeldt, Elmir 
Omerovic. Effects of complete heart block on myocardial function, morphology, and energy 
metabolism in the rat. Europace. 2007 Jun;9(6):411-6. 
II. Truls Råmunddal, Sigfus Gizurarson, Malin Lorentzon, Elmir Omerovic. Antiarrhythmic effects of 
growth hormone—in vivo evidence from small-animal models of acute myocardial infarction and 
invasive electrophysiology. J Electrocardiol. 2008 Mar-Apr;41(2):144-51.
III. Sigfus Gizurarson, Yangzhen Shao, Azra Miljanovic, Truls Råmunddal, Jan Borén, Lennart Bergfeldt, 
Elmir Omerovic. Electrophysiological effects of lysophosphatidylcholine on HL-1 cardiomyocytes 
assessed with a microelectrode array system. Submitted
IV. Sigfus Gizurarson, Marcus Ståhlman, Anders Jeppsson, Yangzhen Shao, Björn Redfors, Lennart 
Bergfeldt, Jan Borén, Elmir Omerovic. Atrial Fibrillation in Patients Admitted to Coronary Care 
Units in Western Sweden - The Role of Obesity and Lipotoxicity. In manuscript
Metabolic aspects of cardiac arrhythmias 
Sigfús Gizurarson, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska 
Academy, University of Gothenburg, Sweden 
 
Cardiac arrhythmias are an important cause of mortality and morbidity in patients with cardiac diseases. Sudden 
death due to ventricular tachycardia and fibrillation (VT/VF) in the setting of acute myocardial infarction (AMI) 
and heart failure (HF) is a frequent cause of premature death. Another recognized cause for sudden cardiac death 
is acquired complete heart block (CHB), a condition where the heart must quickly adapt to volume overload and 
increased wall stress to maintain normal hemodynamics. In the pre-pacemaker era this was a condition with a 
very high mortality mostly due to sudden death and progressive HF. The most common sustained arrhythmia, 
atrial fibrillation causes significant morbidity and is associated with stroke, heart failure and risk of premature 
death. 
The heart is an electro-mechanic pump that metabolizes mostly fatty acids for energy generation. Most of the 
energy is fuelling contractile work but approximately one-third is designated for ion pumps that maintain the 
electrochemical homeostasis of the cardiomyocyte, and give rise to the cell depolarization and repolarization. As 
the ATP pool is completely turned over every 10s, effective metabolism is imperative for the maintenance of 
electrical stability in the cell. In different pathophysiological states, i.e. obesity and diabetes, there is a mismatch 
between uptake and utilization of fatty acids leading to intracellular lipid accumulation. This may lead to the 
production of toxic lipid metabolites (e.g. lysophosphatidylcholine (LPC), diacylglycerol (DAG) and ceramides) 
and is referred to as lipotoxicity. LPC is also generated during myocardial ischemia and has been proposed as a 
contributor to the generation of ventricular arrhythmias during AMI. An import metabolic regulatory hormone, 
growth hormone (GH), has been shown to exert various positive effects in post-infarction HF.  
Aims 
I. To evaluate the short- and long-term effects of CHB on cardiac function, morphology and energy 
metabolism in the rat 
II. To investigate the effects of GH on ischemic and non-ischemic arrhythmogenesis in the rat 
III. To set up and validate an in vitro experimental system for studies of the effects of LPC on 
electrophysiological parameters in beating cardiomyocytes.  
IV. To evaluate associated risk factors for having AF in patients admitted to cardiac care units and to 
evaluate the role of lipid metabolism in the pathophysiology of AF. 
Results and conclusions 
I. Rats with CHB compensate for the reduction in heart rate by doubling the stroke volume and 
thereby maintaining cardiac output. Increases in wall tension leads to eccentric left ventricular 
hypertrophy. After long-term CHB there were no hemodynamic or metabolic signs of HF. 
II. GH reduced the occurrence of spontaneous VT/VF in rats with induced AMI as well as reducing 
induced VT/VF in anesthetized rats. This adds to previously described beneficial effects of GH in 
HF and AMI, and we suggest that the effect is partly mediated via decreased sympathetic 
stimulation. 
III. LPC induced prompt and pronounced electrophysiological alterations that may underlie its 
observed pro-arrhythmic properties. Our model may be a useful tool for preclinical studies of 
electrophysiological effects of various pathophysiological concepts.  
IV. In a multivariate analysis we found that obesity was associated with AF, but diabetes was not. AF 
was associated with quantitative and qualitative alterations in atrial lipid content but not with signs 
of lipotoxicity. Polyunsaturated DAG may play a role in pathophysiology of AF. 
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